Results 41 to 50 of about 64,849 (261)

Efficacy and safety of empagliflozin for treating neutropenia and neutrophil dysfunction in paediatric patients with glycogen storage disease type Ib: A systematic review and meta‐analysis

British Journal of Clinical Pharmacology, EarlyView.
Aims Glycogen storage disease type Ib (GSD‐Ib) is a rare genetic disorder causing neutropenia and neutrophil dysfunction in children. G‐CSF has been the primary treatment, but emerging data support the potential of empagliflozin, an SGLT2 inhibitor, as a promising investigational option.
Elizabeth Iwasyk, Ryan Jin, Fabio Tuzzolino, Giusy Ranucci, Donatella Madonia, Alessio Provenzani   +5 more
wiley   +1 more source

The relation between serum levels of interleukin 10 and interferon-gamma with oral candidiasis in type 2 diabetes mellitus patients

BMC Endocrine Disorders, 2022
Background Type 2 Diabetes mellitus (T2DM) is one of the most common endocrine diseases that weakens the immune system. Candida albicans, is part of the natural oral flora and increases in cases of compromised immune systems.
Atefe Halimi, Nazanin Mortazavi, Ali Memarian, Maryam Zahedi, Farhad Niknejad, Ahmad Sohrabi, Shakiba Javadian Sarraf   +6 more
doaj   +1 more source

Yin and yang of interleukin-17 in host immunity to infection [version 1; referees: 2 approved] [PDF]

, 2017
The interleukin-17 (IL-17) family cytokines, such as IL-17A and IL-17F, play important protective roles in host immune response to a variety of infections such as bacterial, fungal, parasitic, and viral.
Das, Shibali, Khader, Shabaana
core   +3 more sources

Population pharmacokinetic modelling of amoxicillin in human breast milk—A contribution from the ConcePTION project

British Journal of Clinical Pharmacology, EarlyView.
Aims Amoxicillin, a widely used β‐lactam antibiotic, requires improved pharmacokinetic characterization during breastfeeding. This study used a population pharmacokinetic (PopPK) approach to model amoxicillin concentrations in breast milk, identify variability sources and estimate infant exposure, applying worst‐case scenarios.
Sarah Baklouti, Virginie Rigourd, Alice Panchaud, Hedvig Nordeng, Karel Allegaert, Pieter Annaert, Miao‐Chan Huang, Anaelle Monfort, Monia Guidi, Peggy Gandia   +9 more
wiley   +1 more source

A study on the management of corticosteroid side effects in cancer patients [PDF]

, 2015
Background Systemic corticosteroids lead to many adverse effects especially in cancer patients. Preventive measures and treatment options are essential to minimise such side effects.
Fsadni, Clayton John
core  

Candida albicans pathogenicity mechanisms [PDF]

, 2013
Peer reviewedPublisher ...
Alonso-Monge R, Braun BR, Csank C, De Bernardis F, Diez-Orejas R, Fonzi WA, Hube B, Hwang CS, Mühlschlegel FA, Sorger PK, Wysong DR   +10 more
core   +1 more source

Knowledge, Confidence, and Perceptions of Oral Cancer Screening Among Rural and Metropolitan Australian General Dental Practitioners: A Pilot Study

Cancer Nexus, EarlyView.
ABSTRACT Background Oral cancer is a significant public health concern, with disproportionately higher incidence and mortality in rural, regional, and remote Australia. General dental practitioners (GDPs), as frontline providers, are critical to early detection through routine screening.
Bhavika Jindal, Xia Li, Michael Stubbs, Elizabeth Fitriana Sari   +3 more
wiley   +1 more source

Salivary iron and Candida colonization in oral lichen planus patients undergoing topical steroid therapy

BMC Oral Health
Background The most common adverse event in oral lichen planus (OLP) patients undergoing topical corticosteroid therapy is opportunistic infection with oral Candida.
Auranat Prachayakul, Jeerus Sucharitakul, Jaranya Chadsiri, Chanwit Prapinjumrune   +3 more
doaj   +1 more source

FACTORS RELATED TO ORAL CANDIDIASIS IN ELDERLY USERS AND NON-USERS OF REMOVABLE DENTAL PROSTHESES

Revista do Instituto de Medicina Tropical de São Paulo, 2016
This study examined the association between oral candidiasis in elderly users and nonusers of prosthesis and its predisposing factors. To this end, we performed a cross-sectional study where saliva samples from 48 patients were collected they used ...
Cyra Maria Pires de Carvalho BIANCHI, Hélcio Aparecido BIANCHI, Tomoko TADANO, Claudete Rodrigues de PAULA, Hugo Dias HOFFMANN-SANTOS, Diniz Pereira LEITE Jr, Rosane Christine HAHN   +6 more
doaj   +1 more source

The prevalence, risk factors and antifungal sensitivity pattern of oral candidiasis in HIV/AIDS patients in Kumba District Hospital, South West Region, Cameroon

The Pan African Medical Journal, 2020
INTRODUCTION: oral candidiasis is one of the most common opportunistic infection in HIV/AIDS patient and it is caused by Candida species. The low absolute CD4+T-lymphocyte count has traditionally been cited as the greatest risk factor for the development
Ngwa Fabrice Ambe, Njunda Anna Longdoh, Patience Tebid, Tanyi Pride Bobga, Claude Ngwayu Nkfusai, Sangwe Bertrand Ngwa, Frankline Sanyuy Nsai, Samuel Nambile Cumber   +7 more
doaj   +1 more source